Renal transplant recipients who are deficient in 1,25-dihydroxyvitamin D are at higher risk of delayed graft function (DGF), according to a Polish study published in Transplantation Proceedings (2009;41:3002-2005).
The study included 90 renal transplant recipients, all of whom received alfacalcidol before surgery. Investigators identified severe 1,25-dihydroxyvitamin D deficiency in 83% of patients immediately after transplantation. DGF occurred in 44% of those with the deficiency versus 6% of those without a deficiency.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.